Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin

被引:49
作者
Juzeniene, A. [1 ]
Juzenas, P.
Ma, L. -W.
Iani, V.
Moan, J.
机构
[1] Norwegian Radium Hosp, Inst Canc Res, Dept Radiat Biol, N-0310 Oslo, Norway
[2] Univ Oslo, Dept Phys, N-0316 Oslo, Norway
关键词
5-aminolaevulinic acid; hexyl; 5-aminolaevulinate; methyl; photodynamic therapy; protoporphyrin IX;
D O I
10.1111/j.1365-2133.2006.07484.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background 5-Aminolaevulinic acid (ALA) and its ester derivatives are used in photodynamic therapy. Despite extensive investigations, the differences in biodistribution and pharmacokinetics of protoporphyrin IX (PpIX) induced by ALA and its derivatives are still not well understood, notably for humans. Objectives To study porphyrin accumulation after topical application of ALA and two of its ester derivatives in normal human skin. Methods Creams containing 0.2%, 2% and 20% (w/w) of ALA, methyl 5-aminolaevulinate (MAL) and hexyl 5-aminolaevulinate (HAL) were applied on normal human skin of six volunteers. The amount and distribution of porphyrins formed in the skin was investigated noninvasively by means of fluorescence spectroscopy. Results Fluorescence emission and excitation spectra exhibited similar spectral shapes for the all drugs, indicating that mainly PpIX was formed. Low concentrations (0.2% and 2%) of MAL induced considerably less PpIX in normal human skin than similar concentrations of ALA and HAL. A high concentration (20%) of ALA gave higher PpIX fluorescence in normal human skin than was found for MAL and HAL. Conclusions The concentrations inducing half of the maximal PpIX fluorescence are around 2% for ALA, 8% for MAL and 1% for HAL.
引用
收藏
页码:791 / 799
页数:9
相关论文
共 68 条
[1]   FLUORESCENCE ENDOSCOPY INSTRUMENTATION FOR IMPROVED TISSUE CHARACTERIZATION [J].
ANDERSSON, PS ;
MONTAN, S ;
PERSSON, T ;
SVANBERG, S ;
TAPPER, S ;
KARLSSON, SE .
MEDICAL PHYSICS, 1987, 14 (04) :633-636
[2]   Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata [J].
Bissonnette, R ;
Shapiro, J ;
Zeng, H ;
Mclean, DI ;
Lui, H .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) :1032-1035
[3]   SUPERFICIAL PHOTODYNAMIC THERAPY WITH TOPICAL 5-AMINOLEVULINIC ACID FOR SUPERFICIAL PRIMARY AND SECONDARY SKIN-CANCER [J].
CAIRNDUFF, F ;
STRINGER, MR ;
HUDSON, EJ ;
ASH, DV ;
BROWN, SB .
BRITISH JOURNAL OF CANCER, 1994, 69 (03) :605-608
[4]   Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures [J].
Casas, A ;
Batlle, AMD ;
Butler, AR ;
Robertson, D ;
Brown, EH ;
MacRobert, A ;
Riley, PA .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1525-1532
[5]   THE USE OF 5-AMINOLEVULINIC ACID (ALA) IN PHOTODYNAMIC THERAPY (PDT) [J].
CHARLESWORTH, P ;
TRUSCOTT, TG .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1993, 18 (01) :99-100
[6]   In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies [J].
De Rosa, FS ;
Lopez, RFV ;
Thomazine, JA ;
Tedesco, AC ;
Lange, N ;
Bentley, MVLB .
PHARMACEUTICAL RESEARCH, 2004, 21 (12) :2247-2252
[7]   Photodynamic therapy [J].
Dougherty, TJ ;
Gomer, CJ ;
Henderson, BW ;
Jori, G ;
Kessel, D ;
Korbelik, M ;
Moan, J ;
Peng, Q .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :889-905
[8]  
Fritsch C, 1998, PHOTOCHEM PHOTOBIOL, V68, P218
[9]  
Gaullier JM, 1997, CANCER RES, V57, P1481
[10]   A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester [J].
Gerscher, S ;
Connelly, JP ;
van Henegouwen, GMJB ;
MacRobert, AJ ;
Watt, P ;
Rhodes, LE .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (05) :983-990